Comparative Analysis of Three Subgroups in Stage II Stomach Cancer.
10.5230/jkgca.2001.1.1.32
- Author:
Byung Sun SUH
1
;
Byung Sik KIM
;
Yong Ho KIM
;
Jung Whan YOOK
;
Sung Tae OH
;
Wan Soo KIM
;
Kun Choon PARK
Author Information
1. Department of Surgery Gastrointestinal Division, University of Ulsan, College of Medicine and Asan Medical Center, Seoul, Korea. bskim@www.amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Stomach cancer;
Stage II;
Subgroup (T1N2M0);
Up-staging
- MeSH:
Adenocarcinoma;
Follow-Up Studies;
Humans;
Lymph Node Excision;
Lymph Nodes;
Lymphatic Vessels;
Neoplasm Metastasis;
Prognosis;
Recurrence;
Retrospective Studies;
Stomach Neoplasms*;
Stomach*;
Survival Rate
- From:Journal of the Korean Gastric Cancer Association
2001;1(1):32-37
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Three subgroups of stage II stomach cancer (T1N2M0, T2N1M0, T3N0M0) by UICC-TNM staging system show obvious survival difference to each other, which becomes the pitfall of the current staging system. We analyzed the survival and relapse pattern of stage II stomach cancer patients in three subgroups retrospectively to prove the need for change in staging system. MATENRIALS AND METHODS: From July 1989 to December 1995, curative gastric resection was performed in 1,037 patients with gastric adenocarcinoma, and among them 268 patients (26%) were in stage II. The number in each of subgroups (T1N2M0, T2N1M0, and T3N0M0) were 17, 139 and 112 respectively. Survival and relapse pattern were analyzed and median follow up period was 46 months. RESULTS: The 3-year cumulative survival rates of T1N2M0, T2N1M0, and T3N0M0 were 50%, 80%, and 76% respectively (p=0.001). And the 3-year cumulative survival rates of T1N2M0 was comparable to those of 2 subgroups of stage IIIa (T2N2M0, T3N1M0), 47% and 45% (p>0.05). Peritoneal recurrence was the most frequent in T3N0M0. And hematogenous spread was more frequent in T2N1M0 while nodal spread was more frequent in T1N2M0. Ten out of 17 cases of T1N2M0 died of recurrence. Most of them showed submucosal tumor with depressed lesion and mean tumor size was 3.3 cm. CONCLUSION: Up-staging of T1N2M0 should be considered because it has the lowest survival rate and the worst prognosis among the three subgroups of Stage II stomach cancer patients. In early gastric cancer patients with high-risk factors (large tumor size, invasion into the submucosal layer, and lymphatic vessel involvement), lymph node dissection and postoperative adjuvant therapy is recommended in an attempt to prevent recurrence in the form of lymph node metastasis.
